Global Metagenomics Market to Grow at 9.45% During 2025-2033, Impelled by Rising Need for Drug Discovery

December 27, 2024 | Healthcare

According to the latest report by IMARC Group, titled "Metagenomics Market Report by Product (Instruments and Software, Consumables), Technology (Sequencing, Bioinformatics), Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Agriculture), and Region 2025-2033," the global metagenomics market reached a value of USD 619.1 Million in 2024. Metagenomics refers to the research field that assists researchers in studying the characteristics of genetic substances that are acquired from environmental samples. It involves the usage of multiple molecular tools, such as bioinformatics and sequencing techniques, in order to determine the insights of microbial genomes and analyze the structure of the human microbiome. Additionally, it also assists laboratory professionals in identifying the relationship between antimicrobial resistance and pathogens. Apart from this, it also aids in evaluating the microbiomes that are associated with various chronic illnesses to develop personalized medicines and treatments.

Global Metagenomics Market Trends: 

The global market is primarily driven by the rising prevalence of virus-induced infections. This is supported by the sudden outbreak of coronavirus disease (COVID-19) across the globe. Along with this, the increasing incidences of genetic disorders, especially among infants, and the rising geriatric population, which is more susceptible to medical ailments, are also contributing to the market growth. Moreover, continual technological advancements in the genomics industry, such as the widespread adoption of Artificial Intelligence (AI) technology that assists in genome mapping and annotation, are providing a boost to the market growth. Also, the introduction of next-generation sequencing (NGS) services is acting as a major growth-inducing factor. Furthermore, continuous improvements in the healthcare and pharmaceutical sectors are also projected to drive the market further. Some of the other factors contributing to the market growth include the rising demand for clinical diagnostics and drug discovery and increasing investments to conduct extensive research and development (R&D) activities. Looking forward, IMARC Group expects the market value to reach USD 1,454.1 Million by 2033, exhibiting a CAGR of 9.45% during 2025-2033.

Market Summary:

  • On the basis of the product, the market has been bifurcated into instruments and software and consumables.
  • Based on the technology, the market has been classified into sequencing and bioinformatics.
  • On the basis of the application, the market has been categorized into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel and agriculture.
  • Based on the region, the market has been divided into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.
     

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Product, Technology, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Metagenomics Market to Grow at 9.45% During 2025-2033, Impelled by Rising Need for Drug Discovery
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials